MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Stryker Corp

Cerrado

SectorSalud

377.64 1.24

Resumen

Variación precio

24h

Actual

Mínimo

366.48

Máximo

378.27

Métricas clave

By Trading Economics

Ingresos

-288M

546M

Ventas

946M

6.4B

P/B

Media del Sector

48.094

63.778

BPA

4.01

Rentabilidad por dividendo

0.9

Margen de beneficio

8.484

Empleados

53,000

EBITDA

385M

1.8B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+16.61% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.90%

2.39%

Próximas Ganancias

29 abr 2025

Fecha Próximo Dividendo

30 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-8.2B

142B

Apertura anterior

376.4

Cierre anterior

377.64

Noticias sobre sentimiento de mercado

By Acuity

28%

72%

83 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Stryker Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 ene 2025, 21:55 UTC

Ganancias

Stryker Sees Further Organic Sales Growth in 2025

28 ene 2025, 21:46 UTC

Adquisiciones, fusiones, absorciones

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6 ene 2025, 22:18 UTC

Adquisiciones, fusiones, absorciones

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6 ene 2025, 21:39 UTC

Adquisiciones, fusiones, absorciones

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19 feb 2025, 13:53 UTC

Adquisiciones, fusiones, absorciones

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 feb 2025, 13:30 UTC

Adquisiciones, fusiones, absorciones

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 ene 2025, 21:09 UTC

Adquisiciones, fusiones, absorciones

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 ene 2025, 21:09 UTC

Adquisiciones, fusiones, absorciones

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 ene 2025, 21:08 UTC

Adquisiciones, fusiones, absorciones

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 ene 2025, 21:08 UTC

Adquisiciones, fusiones, absorciones

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 ene 2025, 21:06 UTC

Ganancias

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28 ene 2025, 21:06 UTC

Ganancias

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28 ene 2025, 21:05 UTC

Adquisiciones, fusiones, absorciones

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Net $500M >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Adj EPS $4.01 >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Net $546M >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Net $500M >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Sales $6.4B >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q EPS $1.41 >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Adj EPS $4.01 >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q EPS $1.41 >SYK

28 ene 2025, 21:05 UTC

Ganancias

Stryker 4Q Sales $6.4B >SYK

17 ene 2025, 21:20 UTC

Adquisiciones, fusiones, absorciones

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13 ene 2025, 19:30 UTC

Ganancias

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7 ene 2025, 09:58 UTC

Acciones populares

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6 ene 2025, 22:03 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6 ene 2025, 21:49 UTC

Adquisiciones, fusiones, absorciones

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6 ene 2025, 21:24 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6 ene 2025, 21:11 UTC

Adquisiciones, fusiones, absorciones

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6 ene 2025, 21:10 UTC

Adquisiciones, fusiones, absorciones

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Comparación entre iguales

Cambio de precio

Stryker Corp Esperado

Precio Objetivo

By TipRanks

16.61% repunte

Estimación a 12 meses

Media 435.3 USD  16.61%

Máximo 465 USD

Mínimo 400 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stryker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

22 ratings

18

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

372.77 / 374.61Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Neutral Evidence

Sentimiento

By Acuity

83 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.